Literature DB >> 26841763

Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.

John S Sack1, Mian Gao1, Susan E Kiefer1, Joseph E Myers1, John A Newitt1, Sophie Wu1, Chunhong Yan1.   

Abstract

Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) is a serine/threonine kinase involved in the phosphorylation of MAP proteins that regulate microtubule dynamics. Abnormal activity of MARK4 has been proposed to contribute to neurofibrillary tangle formation in Alzheimer's disease. The crystal structure of the catalytic and ubiquitin-associated domains of MARK4 with a potent pyrazolopyrimidine inhibitor has been determined to 2.8 Å resolution with an Rwork of 22.8%. The overall structure of MARK4 is similar to those of the other known MARK isoforms. The inhibitor is located in the ATP-binding site, with the pyrazolopyrimidine group interacting with the inter-lobe hinge region while the aminocyclohexane moiety interacts with the catalytic loop and the DFG motif, forcing the activation loop out of the ATP-binding pocket.

Entities:  

Keywords:  MARK4; PAR-1 serine/threonine protein kinase; transferase

Mesh:

Substances:

Year:  2016        PMID: 26841763      PMCID: PMC4741193          DOI: 10.1107/S2053230X15024747

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  12 in total

Review 1.  An overview of the KIN1/PAR-1/MARK kinase family.

Authors:  Jean-Pierre Tassan; Xavier Le Goff
Journal:  Biol Cell       Date:  2004-04       Impact factor: 4.458

Review 2.  The tau of MARK: a polarized view of the cytoskeleton.

Authors:  Dorthe Matenia; Eva-Maria Mandelkow
Journal:  Trends Biochem Sci       Date:  2009-06-24       Impact factor: 13.807

Review 3.  MAPs, MARKs and microtubule dynamics.

Authors:  G Drewes; A Ebneth; E M Mandelkow
Journal:  Trends Biochem Sci       Date:  1998-08       Impact factor: 13.807

4.  Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2.

Authors:  Alexander Marx; Chanakya Nugoor; Jens Müller; Saravanan Panneerselvam; Thomas Timm; Matthias Bilang; Efstratios Mylonas; Dmitri I Svergun; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

5.  Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study.

Authors:  J Y Chin; R B Knowles; A Schneider; G Drewes; E M Mandelkow; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

6.  MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.

Authors:  Bernhard Trinczek; Miro Brajenovic; Andreas Ebneth; Gerard Drewes
Journal:  J Biol Chem       Date:  2003-11-01       Impact factor: 5.157

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1.

Authors:  Saravanan Panneerselvam; Alexander Marx; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Structure       Date:  2006-02       Impact factor: 5.006

9.  MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.

Authors:  Harald Lund; Elin Gustafsson; Anne Svensson; Maria Nilsson; Margareta Berg; Dan Sunnemark; Gabriel von Euler
Journal:  Acta Neuropathol Commun       Date:  2014-02-17       Impact factor: 7.801

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  10 in total

Review 1.  Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Authors:  Narendran Annadurai; Khushboo Agrawal; Petr Džubák; Marián Hajdúch; Viswanath Das
Journal:  Cell Mol Life Sci       Date:  2017-06-20       Impact factor: 9.261

Review 2.  Regulation of Cell Polarity by PAR-1/MARK Kinase.

Authors:  Youjun Wu; Erik E Griffin
Journal:  Curr Top Dev Biol       Date:  2016-12-05       Impact factor: 4.897

3.  Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation.

Authors:  Anas Shamsi; Debarati DasGupta; Fahad A Alhumaydhi; Mohd Shahnawaz Khan; Suliman A Alsagaby; Waleed Al Abdulmonem; Md Imtaiyaz Hassan; Dharmendra Kumar Yadav
Journal:  RSC Med Chem       Date:  2022-04-20

4.  Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinib.

Authors:  Mingsong Shi; Lun Wang; Kongjun Liu; Yong Chen; Mengshi Hu; Linyu Yang; Jun He; Lijuan Chen; Dingguo Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

5.  Dasatinib-SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics Simulations.

Authors:  Mingsong Shi; Lun Wang; Penghui Li; Jiang Liu; Lijuan Chen; Dingguo Xu
Journal:  ACS Omega       Date:  2021-04-15

6.  MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.

Authors:  Anas Shamsi; Saleha Anwar; Taj Mohammad; Mohamed F Alajmi; Afzal Hussain; Md Tabish Rehman; Gulam Mustafa Hasan; Asimul Islam; Md Imtaiyaz Hassan
Journal:  Biomolecules       Date:  2020-05-20

7.  Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.

Authors:  Maria Voura; Parvez Khan; Savvas Thysiadis; Sotiris Katsamakas; Aarfa Queen; Gulam Mustafa Hasan; Sher Ali; Vasiliki Sarli; Md Imtaiyaz Hassan
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379

8.  Discovery of Coumarin as Microtubule Affinity-Regulating Kinase 4 Inhibitor That Sensitize Hepatocellular Carcinoma to Paclitaxel.

Authors:  Xianyan Shen; Xuesha Liu; Shunli Wan; Xin Fan; Huaiyu He; Rong Wei; Wenchen Pu; Yong Peng; Chun Wang
Journal:  Front Chem       Date:  2019-05-24       Impact factor: 5.221

9.  Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors.

Authors:  Nashrah Sharif Khan; Parvez Khan; Afreen Inam; Kamal Ahmad; Mohd Yousuf; Asimul Islam; Sher Ali; Amir Azam; Mohammad Husain; Md Imtaiyaz Hassan
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 3.361

10.  Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.

Authors:  Ghulam Md Ashraf; Debarati DasGupta; Mohammad Zubair Alam; Saleh S Baeesa; Badrah S Alghamdi; Firoz Anwar; Thamer M A Alqurashi; Sharaf E Sharaf; Waleed Al Abdulmonem; Mohammed A Alyousef; Fahad A Alhumaydhi; Anas Shamsi
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.